Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Business Wire•03/11/2026•06:00 ET
0
Key Highlights
- ➤FY2026 non-GAAP diluted EPS guidance raised to $5.50-$5.56
- ➤Q3 GAAP diluted EPS $1.06, up 26.2% year over year
- ➤Q3 non-GAAP diluted EPS $1.56, up 13.0% year over year
- ➤Q3 sales $3.5 billion, up 4.0% overall
- ➤U.S. dental merchandise sales grew 8.6%, driven primarily by volume
Expert Statements
Fred Lowery, Chief Executive Officer of Henry Schein
“We delivered another strong quarter that increases our confidence in the momentum we are building at Henry Schein. I am very pleased with the U.S. dental merchandise sales growth of 8.6% driven primarily by volume in a stable market and our 19% adjusted earnings per share growth(4),”
Fred Lowery, Chief Executive Officer of Henry Schein
“Our strategy is translating into stronger financial results. We are gaining share in key businesses, improving our portfolio mix, maintaining a disciplined approach to capital allocation, and realizing the benefits of our value creation initiatives”
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
* Q3 2026 GAAP diluted EPS of $1.06, up 26.2% versus prior year; Q3 2026 non-GAAP diluted EPS of $1.56, up 13.0% versus prior year
Get started
Create a free account to read the full story.